Cargando…
N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer
BACKGROUND: Several recent studies have confirmed epigenetic regulation of the immune response. However, the potential role of RNA N6-methyladenosine (m(6)A) modifications in cervical cancer and tumour microenvironment (TME) cell infiltration remain unclear. RESULTS: We evaluated and analysed m(6)A...
Autores principales: | Zhang, He, Kong, Weimin, Zhao, Xiaoling, Han, Chao, Liu, Tingting, Li, Jing, Song, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767716/ https://www.ncbi.nlm.nih.gov/pubmed/35042477 http://dx.doi.org/10.1186/s12863-022-01024-2 |
Ejemplares similares
-
The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020) -
N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022) -
m(6)A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
por: Xu, Feng, et al.
Publicado: (2021) -
Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer
por: Zuo, Luo, et al.
Publicado: (2021) -
N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)